U.S. Food and Drug Administration recently issued the following announcement.
Nelarabine (Arranon) Injection
Status: Currently in Shortage
»Date first posted: 10/30/2018
»Therapeutic Categories: Hematology
Novartis (Reverified 03/25/2019)
Company Contact Information: 888-669-6682
Presentation: 250 mg/50 mL (NDC 0078-0683-06)
Availability and Estimated Shortage Duration: Limited availability at wholesalers. Estimated Shortage Duration: TBD
Shortage Reason (per FDASIA): Demand increase for the drug
Original source can be found here.
